Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças

Detalhes bibliográficos
Autor(a) principal: Fernandes, Morgana Thaís Carollo
Data de Publicação: 2019
Tipo de documento: Tese
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da PUC_RS
Texto Completo: http://tede2.pucrs.br/tede2/handle/tede/9081
Resumo: Introduction: Detecting airway changes is very important for treatment and diagnosis of asthmatic children. For the efficient and cost-effective adoption of treatment options directed at daily clinical practice, reliable and well-defined biomarkers contribute to the identification of asthma phenotypes and endotypes that are most likely to respond. In this scenario, the forced oscillation technique (FOT) is a promising method in the diagnosis and monitoring of respiratory diseases. Objective: To evidence forced oscillation technique (FOT) parameters that may be used as biomarkers for the diagnosis and monitoring of asthma. Methods: cross-sectional observational study with a quantitative approach. The sample consisted of children and adolescents with asthma and healthy controls, aged 3 to 17 years old, recruited from the São Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS). The anthropometry, clinical history and respiratory impedance measurements were obtained in all participants. The Research Ethics Committee of the educational institution under opinion No. 3,100,553 approved the project and informed consent was obtained from all participants and their guardians. Results: A total of 101 individuals (61 males) were recruited, 38 with asthma (Asthma group) and 63 healthy controls (Control group). Pre-bronchodilator spectral measurements showed that all variables had significant differences (p <0.001), with higher resistance and lower (negative) reactance in the asthmatic group. In the within-breath analysis, we observed that in the measurements taken before bronchodilator administration, the differences were significant between the two groups, with p≤0.001 in all comparisons except in the difference between mean inspiratory resistance and expiration (dRmean). The accuracy of resistance measures to discriminate asthma was 0.94 for ReE, 0.89 for ReI and 0.76 for ReE-ReI and for reactance was 0.91 for XeE, 0.91 for XeI and 0.79 to XeE-XeI. Correcting estimates of accuracy, sensitivity, specificity, and area under the curve by confounders (stature) on the ROC curve did not change the results. Conclusions: The data obtained suggest that within-breath FOT measurements have excellent discriminatory power for asthma in children and adolescents. Measurement of impedance may aid in the diagnosis of asthma, may also assess the effect of treatment on pulmonary function, and may be used alone or as a complementary method to spirometry. In our sample, the resistance measures had the best discrimination performance.
id P_RS_fcd2caea3174c70905ae27810ffb415b
oai_identifier_str oai:tede2.pucrs.br:tede/9081
network_acronym_str P_RS
network_name_str Biblioteca Digital de Teses e Dissertações da PUC_RS
repository_id_str
spelling Jones, Marcus Herberthttp://lattes.cnpq.br/2057491798074403http://lattes.cnpq.br/7890106575135063Fernandes, Morgana Thaís Carollo2020-01-31T12:32:59Z2019-08-30http://tede2.pucrs.br/tede2/handle/tede/9081Introduction: Detecting airway changes is very important for treatment and diagnosis of asthmatic children. For the efficient and cost-effective adoption of treatment options directed at daily clinical practice, reliable and well-defined biomarkers contribute to the identification of asthma phenotypes and endotypes that are most likely to respond. In this scenario, the forced oscillation technique (FOT) is a promising method in the diagnosis and monitoring of respiratory diseases. Objective: To evidence forced oscillation technique (FOT) parameters that may be used as biomarkers for the diagnosis and monitoring of asthma. Methods: cross-sectional observational study with a quantitative approach. The sample consisted of children and adolescents with asthma and healthy controls, aged 3 to 17 years old, recruited from the São Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS). The anthropometry, clinical history and respiratory impedance measurements were obtained in all participants. The Research Ethics Committee of the educational institution under opinion No. 3,100,553 approved the project and informed consent was obtained from all participants and their guardians. Results: A total of 101 individuals (61 males) were recruited, 38 with asthma (Asthma group) and 63 healthy controls (Control group). Pre-bronchodilator spectral measurements showed that all variables had significant differences (p <0.001), with higher resistance and lower (negative) reactance in the asthmatic group. In the within-breath analysis, we observed that in the measurements taken before bronchodilator administration, the differences were significant between the two groups, with p≤0.001 in all comparisons except in the difference between mean inspiratory resistance and expiration (dRmean). The accuracy of resistance measures to discriminate asthma was 0.94 for ReE, 0.89 for ReI and 0.76 for ReE-ReI and for reactance was 0.91 for XeE, 0.91 for XeI and 0.79 to XeE-XeI. Correcting estimates of accuracy, sensitivity, specificity, and area under the curve by confounders (stature) on the ROC curve did not change the results. Conclusions: The data obtained suggest that within-breath FOT measurements have excellent discriminatory power for asthma in children and adolescents. Measurement of impedance may aid in the diagnosis of asthma, may also assess the effect of treatment on pulmonary function, and may be used alone or as a complementary method to spirometry. In our sample, the resistance measures had the best discrimination performance.Introdução: Detectar alterações das vias aéreas é muito importante para o manejo e diagnóstico de crianças asmáticas. Para a adoção eficiente e custo-efetivo de opções de tratamento direcionadas à prática clínica diária, biomarcadores confiáveis e bem definidos contribuem na identificação de fenótipos e endotipos de asma com maior probabilidade de resposta. Nesse cenário, a técnica de oscilações forçadas (FOT) é um método promissor na monitorização e diagnóstico de doenças respiratórias. Objetivo: evidenciar parâmetros da técnica de oscilações forçadas (FOT) que possam ser utilizados como biomarcadores para o diagnóstico e monitoramento da asma. Métodos: estudo transversal, observacional com abordagem quantitativa. A amostra foi composta por crianças e adolescentes com asma e controles saudáveis, entre 3 e 17 anos de idade, recrutados no Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). A antropometria, história clínica e medidas da impedância respiratória foram obtidas em todos os participantes. O projeto foi aprovado pelo Comitê de Ética em Pesquisa da instituição de ensino sob parecer nº: 3.100.553 e o consentimento informado foi obtido de todos os participantes e seus responsáveis. Resultados: Foram recrutados 101 indivíduos (61 do sexo masculino), sendo 38 portadores de asma (grupo Asma) e 63 controles sadios (grupo Controle). Nas medidas espectrais pré broncodilatador observou-se que todas as variáveis apresentam diferenças significativas (p<0,001), com resistência mais alta e a reatância mais baixa (negativa) no grupo de asmáticos. Na análise within-breath observou-se que nas medidas realizadas antes da administração do broncodilatador as diferenças são significativas entre os dois grupos, com p≤0,001 em todas as comparações exceto na diferença entre a resistência média da inspiração e a expiração (dRmean). A acurácia das medidas de resistência para discriminar asma foi de 0,94 para ReE, 0,89 para ReI e 0,76 para ReE-ReI e para reatância foi de 0,91 para XeE, 0,91 para XeI e 0,79 para XeE-XeI. A correção das estimativas de acurácia, sensibilidade, especificidade e área sob a curva por confundidores (estatura) na curva ROC não modificou os resultados. Conclusões: os dados obtidos sugerem que as medidas de FOT within-breath tem excelente poder discriminatório para asma em crianças e adolescentes. A medida da impedância pode ajudar no diagnóstico de asma e também avaliar o efeito do tratamento na função pulmonar, podendo ser utilizada isoladamente ou como método complementar à espirometria. Na nossa amostra as medidas de resistência foram as que tiveram melhor performance de discriminação.Submitted by PPG Pediatria e Saúde da Criança (pediatria-pg@pucrs.br) on 2020-01-20T18:04:04Z No. of bitstreams: 1 Tese Morgana versão final pós banca.pdf: 2572773 bytes, checksum: 18b553626ae506b84ba17f1c19ec81c1 (MD5)Approved for entry into archive by Sheila Dias (sheila.dias@pucrs.br) on 2020-01-31T12:32:47Z (GMT) No. of bitstreams: 1 Tese Morgana versão final pós banca.pdf: 2572773 bytes, checksum: 18b553626ae506b84ba17f1c19ec81c1 (MD5)Made available in DSpace on 2020-01-31T12:32:59Z (GMT). No. of bitstreams: 1 Tese Morgana versão final pós banca.pdf: 2572773 bytes, checksum: 18b553626ae506b84ba17f1c19ec81c1 (MD5) Previous issue date: 2019-08-30Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfhttp://tede2.pucrs.br:80/tede2/retrieve/177541/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpgporPontifícia Universidade Católica do Rio Grande do SulPrograma de Pós-Graduação em Medicina/Pediatria e Saúde da CriançaPUCRSBrasilEscola de Medicina1. Global Initiative For Asthma. Global Strategy for Asthma Management and Prevention; 2018. Available from: www.ginasthma.org. 2. Terzano C, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, et al. 1-year prospective real life monitoring of asthma control and quality of life in Italy. Respiratory Research. 2012. 3. Braman SS. The global burden of asthma. In: Chest. 2006. 4. Pitrez PM, Stein RT. Asthma in Latin America: the dawn of a new epidemic. Current Opinion in Allergy and Clinical Immunology. 2008. 5. Wehrmeister FC, Menezes AMB, Cascaes AM, Martínez-Mesa J, Barros AJD. Time trend of asthma in children and adolescents in Brazil, 1998-2008. Rev Saude Publica. 2012; 6. Cardoso TDA, Roncada C, Rodrigues E, Pinto LA, Jones MH, Stein RT, et al. Impacto da asma no Brasil : análise longitudinal de dados extraídos de um banco de dados governamental brasileiro. J Bras Pneumol. 2017; 7. Beasley R, Keil U, Von Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998; 8. Sánchez-Cuéllar S, Bermúdez JA. El uso de los biomarcadores de inflamación en la vía aérea en el manejo del asma. Revista de Patologia Respiratoria. 2012. 9. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22222128 10. V Vidal PC, Mattiello R, Jones MH, Herbert Jones M. Espirometria em Pré-Escolares Spirometry in Preschool Children Endereço para correspondência. Vol. 22. 2013. 11. Allen JL. Input oscillometry and the forced oscillation technique for assessing lung function in preschool children with asthma. Pediatr Investig. 2018; 12. Chong Neto HJ, Solé D, Camargos P, Rosário NA, Sarinho EC, Chong-Silva DC, et al. Diretrizes da Associação Brasileira de Alergia e Imunologia e Sociedade Brasileira de Pediatria para sibilância e asma no pré-escolar. Arq Asma, Alerg e Imunol. 2018; 13. Brashier B, Salvi S. Measuring lung function using sound waves: Role of the forced oscillation technique and impulse oscillometry system. Breathe [Internet]. 2015 Mar [cited 2015 Dec 28];11(1):57–65. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4487383&tool=pmcentrez&rendertype=abstract 14. Farré R, Rotger M, Marchal F, Peslin R, Navajas D. Assessment of bronchial reactivity by forced oscillation admittance avoids the upper airway artefact. Eur Respir J [Internet]. 1999;13(4):761–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10362037 15. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HGM, Aurora P, et al. An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary function testing in preschool children. American Journal of Respiratory and Critical Care Medicine. 2007. 16. Valle E. Resistência das vias aéreas : técnica da oscilação forçada. J Pneumol. 2002; 17. De Assumpção MS, Gonçalves RM, Ferreira LG, Schivinski CIS. Sistema de oscilometria de impulso em pediatria: Revisão de literatura. Medicina (Brazil). 2014. 18. Czövek D, Shackleton C, Hantos Z, Taylor K, Kumar A, Chacko A, et al. Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children. Thorax [Internet]. 2016 Oct [cited 2019 Aug 4];71(10):907–15. Available from: http://thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2015-208182 19. Bates JHT, Irvin CG, Farré R, Hantos Z. Oscillation mechanics of the respiratory system. Compr Physiol [Internet]. 2011 [cited 2018 Dec 1];1(3):1233–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22011237 20. Gray D, Cz??vek D, Smith E, Willemse L, Alberts A, Gingl Z, et al. Respiratory impedance in healthy unsedated South African infants: Effects of maternal smoking. Respirology [Internet]. 2015 Apr [cited 2016 Jan 24];20(3):467–73. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4670479&tool=pmcentrez&rendertype=abstract 21. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J [Internet]. 2003;22(6):1026–41. Available from: http://erj.ersjournals.com/cgi/doi/10.1183/09031936.03.00089403 22. Sly PD, Hayden MJ, Peták F, Hantos Z, Sly PD Petak F, Hantos Z HMJ. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 23. Sly PD, Hayden MJ, Peták F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 24. Lambrecht, B. N., & Hammad, H. (2015). The immunology of asthma. Nature immunology, 16(1), 45.25. Fórum Internacional de Sociedades Respiratórias. O Impacto Global da Doença Respiratória. European Respiratory Society. 2017. 26. Vasconcelos MM, Accioly LS, Leão MJCC, Lima DST, Aguiar Filho AS, Lopes Neto EPA, et al. Conceitos de asma e instrumentos de levantamentos epidemiológicos de prevalência. Rev Port Pneumol. 2015; 27. Wallace J, Denk C, Kruse L. PEER REVIEWED: Pediatric Hospitalizations for Asthma: Use of a Linked File to Separate Person-level Risk and Readmission. Prev Chronic Dis. 2004; 28. Cookson W. The alliance of genes and environment in asthma and allergy. Nature. 2002; 29. Busse WW, Lemanske Jr. RF. Asthma. N Engl J Med. 2001; 30. Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, et al. The burden of severe asthma in childhood and adolescence: Results from the paediatric U-BIOPRED cohorts. In: European Respiratory Journal. 2015. 31. Gray D, Willemse L, Visagie A, Czövek D, Nduru P, Vanker A, et al. Determinants of early-life lung function in African infants. Thorax. 2016; 32. Malmberg LP, Pelkonen a, Poussa T, Pohianpalo a, Haahtela T, Turpeinen M. Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging [Internet]. 2002 Jan [cited 2016 Jan 6];22(1):64–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12003103 33. Hall GL, Hantos Z, Petak F, Wildhaber JH, Tiller K, Burton PR, et al. Airway and respiratory tissue mechanics in normal infants. Am J Respir Crit Care Med [Internet]. 2000;162(4 I):1397–402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11029351 34. Sole D, Aranda CS, Wandalsen GF. Asthma: epidemiology of disease control in Latin America - short review. Asthma Res Pr [Internet]. 2017/05/17. 2017;3:4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28507765 35. Solé D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK, Group I-B. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3. J Pediatr (Rio J). 2006; 36. Sole D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC. Asthma in children and adolescents in Brazil: contribution of the International Study of Asthma and Allergies in Childhood (ISAAC). Rev Paul Pediatr. 2014; 37. Roncada C, de Oliveira SG, Cidade SF. et al. Burden of asthma among inner-city children from Southern Brazil. J Asthma. 2016; 38. Campos HS. Asma: suas origens, seus mecanismos inflamatórios e o papel do corticosteróide. Rev Bras Pneumol Sanitária. 2007; 39. Holgate ST. Pathogenesis of Asthma. In: Allergy and Allergic Diseases, Second Edition. 2009. 40. V Kumar, Jon C. Aster AA. Robbins & Cotran Patologia - Bases Patológicas das Doenças. Elsevier Brasil. 2015. 41. Martínez Aguilar NE. [Pathogenesis, trigger and risk factors in asthma]. Rev Alerg Mex. 2009; 42. Cockcroft DW. Direct challenge tests: Airway hyperresponsiveness in asthma: Its measurement and clinical significance. Chest. 2010. 43. Diagnóstico clínico e funcional da asma brônquica. Rev Assoc Med Bras. 2004; 44. Souza-Machado C, Souza-Machado A, Franco R, Ponte E V., Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J. 2010; 45. Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 46. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004; 47. LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: Validation of the Asthma Control Scoring System. Allergy Eur J Allergy Clin Immunol. 2007; 48. Using beta 2-stimulants in asthma. Drug Ther Bull [Internet]. 1997 Jan [cited 2019 Aug 9];35(1):1–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9282409 49. Adams, N, Bestall, J, Malouf R, et al. Beclomethasone versus placebo for chronic asthma ( Review ). Cochrane. 2008; 50. O’Byrne PM, Reddel HK, Eriksson G, Östlund O, Peterson S, Sears MR, et al. Measuring asthma control: A comparison of three classification systems. Eur Respir J. 2010; 51. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: An integrated analysis of zafirlukast trials. Thorax. 2000; 52. Drazen JM, Israel E, OʼByrne PM. Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. Surv Anesthesiol. 1999; 53. Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, et al. Low-dose inhaled fluticasone propionate versus oral zaf irlukast in the treatment of persistent asthma. J Allergy Clin Immunol. 2000; 54. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: An evidence-based approach. Med J Aust. 2003; 55. Diamant Z, Vijverberg S, Alving K, Bakirtas A, Bjermer L, Custovic A, et al. Towards clinically applicable biomarkers for asthma – An EAACI position paper . Allergy. 2019; 56. Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy: European Journal of Allergy and Clinical Immunology. 2015. 57. Hekking PP, Loza MJ, Pavlidis S, de Meulder B, Lefaudeux D, Baribaud F, et al. Pathway discovery using transcriptomic profiles in adult-onset severe asthma. J Allergy Clin Immunol. 2018; 58. Hekking PP, Loza MJ, Pavlidis S, De Meulder B, Lefaudeux D, Baribaud F, et al. Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J. 2017; 59. Zissler UM, Esser-Von Bieren J, Jakwerth CA, Chaker AM, Schmidt-Weber CB. Current and future biomarkers in allergic asthma. Allergy: European Journal of Allergy and Clinical Immunology. 2016. 60. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med [Internet]. 2009/06/02. 2009;180(5):388–95. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19483109 61. Reis AP dos, Machado JAN. Biomarcadores e imunobiológicos na asma. Brazilian J Allergy Immunol. 2019; 62. Almstrand AC, Ljungstrom E, Lausmaa, J. et al. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Analytical Chemistry. 2009. 63. Trivedi A, Hall C, Hoffman EA, Woods JC, Gierada DS. Clinical reviews in allergy and immunology Using imaging as a biomarker for asthma. J Allergy Clin Immunol. 2017; 64. Normansell R, Walker S, Milan SJ, Walters EH, P. N. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;13(1):1–109. 65. Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, et al. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma. N Engl J Med. 2014; 66. Nair P, Pizzichini MMM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia. N Engl J Med. 2009; 67. Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, et al. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma. N Engl J Med. 2014; 68. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial. Lancet. 2012; 69. Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015; 70. Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. In: Chest. 2016. 71. Castro M, Wenzel, SE. Bleecker ER. et al. Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: A phase 2b randomised dose-ranging study. The Lancet Respiratory Medicine. 2014. 72. Pereira CAC. Espirometria. J Pneumol . 2002;28. 73. Cruz AA, Fernandes AL, Pizzichini E, Fiterman J, Pereira LF, Pizzichini M, et al. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma - 2012. J Bras Pneumol 2012. 38:S1-46. 74. Pereira CADC. CONSENSO DE Espirometria. J Bras Pneumol. 2002; 75. Burity EF, Pereira CA de C, Rizzo JÂ, Sarinho ESC, Jones MH. Efeito da terminação precoce da expiração nos parâmetros espirométricos em crianças pré-escolares saudáveis. J Bras Pneumol. 2011; 76. França DC, Camargos PAM, Jones MH, Martins JA, Vieira B da SPP, Colosimo EA, et al. Prediction equations for spirometry in four‐ to six‐year‐old children. J Pediatr (Versão em Port. 2016; 77. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85–99. Available from: http://rc.rcjournal.com/cgi/doi/10.4187/respcare.01411 78. MacLeod D, Birch M. Respiratory input impedance measurement: Forced oscillation methods. Medical and Biological Engineering and Computing. 2001. 79. Sly PD, Hayden MJ, Peták F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med. 1996; 80. Bates JHT. Systems physiology of the airways in health and obstructive pulmonary disease. Wiley Interdiscip Rev Syst Biol Med. 2016; 81. Melo PL. Forced oscillation technique in pulmonology practice: principles and examples of potential applications. Pulmão RJ. 2015;24(1):42-48. 82. Shirai T, Kurosawa H. Clinical Application of the Forced Oscillation Technique. Intern Med [Internet]. 2016;55(6):559–66. Available from: https://www.jstage.jst.go.jp/article/internalmedicine/55/6/55_55.5876/_article 83. Johnson MK, Birch M, Carter R, et al. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax 2007; 62: 299–306. 84. Lorx A, Czovek D, Gingl Z, Makan G, Radics B, Bartusek D, et al. Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure. Eur Respir J [Internet]. 2017/02/17. 2017;49(2). Available from: https://www.ncbi.nlm.nih.gov/pubmed/28202552 85. Silva KKD da, Faria ACD, Lopes AJ, Melo PL de. Within-breath respiratory impedance and airway obstruction in patients with chronic obstructive pulmonary disease. Clin (São Paulo, Brazil) [Internet]. 2015 Jul [cited 2016 Jan 28];70(7):461–9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4496751&tool=pmcentrez&rendertype=abstract 86. Davidson RN Hussain A, Saunders KB GCA. Within-breath changes of airway calibre in patients with airflow obstruction by continuous measurement of respiratory impedance. Br J Dis Chest. 1986;80(4):335–52. 87. Veras TN, Pinto LA. Viabilidade da realização de espirometria em pré-escolares. J Bras Pneumol. 2011; 88. World Health Organization. Growth reference data for 5-19 years. Who Child Growth Stand. 2013; 89. de Onis M, Garza C, Onyango AW, Borghi E. Comparison of the WHO Child Growth Standards and the CDC 2000 Growth Charts. J Nutr. 2007; 90. Brasil. Resolução No 466, de 12 de dezembro de 2012. Diário of da União. 2012;557290555552975733500500500600600600-224747486637135387-969369452308786627-7702826533010964327-80674179539253457523590462550136975366Técnica de Oscilações ForçadasTeste de Função PulmonarImpedância RespiratóriaCriançaAsmaForced Oscillation TechniqueRespiratory Function TestsRespiratory MechanicsChildAsthmaCIENCIAS DA SAUDE::MEDICINACIENCIAS DA SAUDE::ENFERMAGEMMEDICINA::SAUDE MATERNO-INFANTILAcurácia das medidas de impedância respiratória para o diagnóstico de asma em criançasinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisTrabalho será publicado como artigo ou livro60 meses31/01/2025info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da PUC_RSinstname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)instacron:PUC_RSTHUMBNAILTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpgTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpgimage/jpeg4087http://tede2.pucrs.br/tede2/bitstream/tede/9081/4/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpg986ee145064af681f7777c316248e20cMD54TEXTTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txtTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txttext/plain1698http://tede2.pucrs.br/tede2/bitstream/tede/9081/3/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txtd16dc4aa8644cd0d4df8d4e5068696e0MD53ORIGINALTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdfTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdfapplication/pdf705739http://tede2.pucrs.br/tede2/bitstream/tede/9081/2/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf35ffca4b472da18ca6d4d8fd09c9906fMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8590http://tede2.pucrs.br/tede2/bitstream/tede/9081/1/license.txt220e11f2d3ba5354f917c7035aadef24MD51tede/90812020-01-31 12:00:14.138oai:tede2.pucrs.br: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Biblioteca Digital de Teses e Dissertaçõeshttp://tede2.pucrs.br/tede2/PRIhttps://tede2.pucrs.br/oai/requestbiblioteca.central@pucrs.br||opendoar:2020-01-31T14:00:14Biblioteca Digital de Teses e Dissertações da PUC_RS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)false
dc.title.por.fl_str_mv Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
title Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
spellingShingle Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
Fernandes, Morgana Thaís Carollo
Técnica de Oscilações Forçadas
Teste de Função Pulmonar
Impedância Respiratória
Criança
Asma
Forced Oscillation Technique
Respiratory Function Tests
Respiratory Mechanics
Child
Asthma
CIENCIAS DA SAUDE::MEDICINA
CIENCIAS DA SAUDE::ENFERMAGEM
MEDICINA::SAUDE MATERNO-INFANTIL
title_short Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
title_full Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
title_fullStr Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
title_full_unstemmed Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
title_sort Acurácia das medidas de impedância respiratória para o diagnóstico de asma em crianças
author Fernandes, Morgana Thaís Carollo
author_facet Fernandes, Morgana Thaís Carollo
author_role author
dc.contributor.advisor1.fl_str_mv Jones, Marcus Herbert
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/2057491798074403
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/7890106575135063
dc.contributor.author.fl_str_mv Fernandes, Morgana Thaís Carollo
contributor_str_mv Jones, Marcus Herbert
dc.subject.por.fl_str_mv Técnica de Oscilações Forçadas
Teste de Função Pulmonar
Impedância Respiratória
Criança
Asma
topic Técnica de Oscilações Forçadas
Teste de Função Pulmonar
Impedância Respiratória
Criança
Asma
Forced Oscillation Technique
Respiratory Function Tests
Respiratory Mechanics
Child
Asthma
CIENCIAS DA SAUDE::MEDICINA
CIENCIAS DA SAUDE::ENFERMAGEM
MEDICINA::SAUDE MATERNO-INFANTIL
dc.subject.eng.fl_str_mv Forced Oscillation Technique
Respiratory Function Tests
Respiratory Mechanics
Child
Asthma
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA
CIENCIAS DA SAUDE::ENFERMAGEM
MEDICINA::SAUDE MATERNO-INFANTIL
description Introduction: Detecting airway changes is very important for treatment and diagnosis of asthmatic children. For the efficient and cost-effective adoption of treatment options directed at daily clinical practice, reliable and well-defined biomarkers contribute to the identification of asthma phenotypes and endotypes that are most likely to respond. In this scenario, the forced oscillation technique (FOT) is a promising method in the diagnosis and monitoring of respiratory diseases. Objective: To evidence forced oscillation technique (FOT) parameters that may be used as biomarkers for the diagnosis and monitoring of asthma. Methods: cross-sectional observational study with a quantitative approach. The sample consisted of children and adolescents with asthma and healthy controls, aged 3 to 17 years old, recruited from the São Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS). The anthropometry, clinical history and respiratory impedance measurements were obtained in all participants. The Research Ethics Committee of the educational institution under opinion No. 3,100,553 approved the project and informed consent was obtained from all participants and their guardians. Results: A total of 101 individuals (61 males) were recruited, 38 with asthma (Asthma group) and 63 healthy controls (Control group). Pre-bronchodilator spectral measurements showed that all variables had significant differences (p <0.001), with higher resistance and lower (negative) reactance in the asthmatic group. In the within-breath analysis, we observed that in the measurements taken before bronchodilator administration, the differences were significant between the two groups, with p≤0.001 in all comparisons except in the difference between mean inspiratory resistance and expiration (dRmean). The accuracy of resistance measures to discriminate asthma was 0.94 for ReE, 0.89 for ReI and 0.76 for ReE-ReI and for reactance was 0.91 for XeE, 0.91 for XeI and 0.79 to XeE-XeI. Correcting estimates of accuracy, sensitivity, specificity, and area under the curve by confounders (stature) on the ROC curve did not change the results. Conclusions: The data obtained suggest that within-breath FOT measurements have excellent discriminatory power for asthma in children and adolescents. Measurement of impedance may aid in the diagnosis of asthma, may also assess the effect of treatment on pulmonary function, and may be used alone or as a complementary method to spirometry. In our sample, the resistance measures had the best discrimination performance.
publishDate 2019
dc.date.issued.fl_str_mv 2019-08-30
dc.date.accessioned.fl_str_mv 2020-01-31T12:32:59Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://tede2.pucrs.br/tede2/handle/tede/9081
url http://tede2.pucrs.br/tede2/handle/tede/9081
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 557290555552975733
dc.relation.confidence.fl_str_mv 500
500
500
600
600
600
dc.relation.department.fl_str_mv -224747486637135387
dc.relation.cnpq.fl_str_mv -969369452308786627
-7702826533010964327
-8067417953925345752
dc.relation.sponsorship.fl_str_mv 3590462550136975366
dc.relation.references.por.fl_str_mv 1. Global Initiative For Asthma. Global Strategy for Asthma Management and Prevention; 2018. Available from: www.ginasthma.org. 2. Terzano C, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, et al. 1-year prospective real life monitoring of asthma control and quality of life in Italy. Respiratory Research. 2012. 3. Braman SS. The global burden of asthma. In: Chest. 2006. 4. Pitrez PM, Stein RT. Asthma in Latin America: the dawn of a new epidemic. Current Opinion in Allergy and Clinical Immunology. 2008. 5. Wehrmeister FC, Menezes AMB, Cascaes AM, Martínez-Mesa J, Barros AJD. Time trend of asthma in children and adolescents in Brazil, 1998-2008. Rev Saude Publica. 2012; 6. Cardoso TDA, Roncada C, Rodrigues E, Pinto LA, Jones MH, Stein RT, et al. Impacto da asma no Brasil : análise longitudinal de dados extraídos de um banco de dados governamental brasileiro. J Bras Pneumol. 2017; 7. Beasley R, Keil U, Von Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998; 8. Sánchez-Cuéllar S, Bermúdez JA. El uso de los biomarcadores de inflamación en la vía aérea en el manejo del asma. Revista de Patologia Respiratoria. 2012. 9. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22222128 10. V Vidal PC, Mattiello R, Jones MH, Herbert Jones M. Espirometria em Pré-Escolares Spirometry in Preschool Children Endereço para correspondência. Vol. 22. 2013. 11. Allen JL. Input oscillometry and the forced oscillation technique for assessing lung function in preschool children with asthma. Pediatr Investig. 2018; 12. Chong Neto HJ, Solé D, Camargos P, Rosário NA, Sarinho EC, Chong-Silva DC, et al. Diretrizes da Associação Brasileira de Alergia e Imunologia e Sociedade Brasileira de Pediatria para sibilância e asma no pré-escolar. Arq Asma, Alerg e Imunol. 2018; 13. Brashier B, Salvi S. Measuring lung function using sound waves: Role of the forced oscillation technique and impulse oscillometry system. Breathe [Internet]. 2015 Mar [cited 2015 Dec 28];11(1):57–65. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4487383&tool=pmcentrez&rendertype=abstract 14. Farré R, Rotger M, Marchal F, Peslin R, Navajas D. Assessment of bronchial reactivity by forced oscillation admittance avoids the upper airway artefact. Eur Respir J [Internet]. 1999;13(4):761–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10362037 15. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HGM, Aurora P, et al. An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary function testing in preschool children. American Journal of Respiratory and Critical Care Medicine. 2007. 16. Valle E. Resistência das vias aéreas : técnica da oscilação forçada. J Pneumol. 2002; 17. De Assumpção MS, Gonçalves RM, Ferreira LG, Schivinski CIS. Sistema de oscilometria de impulso em pediatria: Revisão de literatura. Medicina (Brazil). 2014. 18. Czövek D, Shackleton C, Hantos Z, Taylor K, Kumar A, Chacko A, et al. Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children. Thorax [Internet]. 2016 Oct [cited 2019 Aug 4];71(10):907–15. Available from: http://thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2015-208182 19. Bates JHT, Irvin CG, Farré R, Hantos Z. Oscillation mechanics of the respiratory system. Compr Physiol [Internet]. 2011 [cited 2018 Dec 1];1(3):1233–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22011237 20. Gray D, Cz??vek D, Smith E, Willemse L, Alberts A, Gingl Z, et al. Respiratory impedance in healthy unsedated South African infants: Effects of maternal smoking. Respirology [Internet]. 2015 Apr [cited 2016 Jan 24];20(3):467–73. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4670479&tool=pmcentrez&rendertype=abstract 21. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J [Internet]. 2003;22(6):1026–41. Available from: http://erj.ersjournals.com/cgi/doi/10.1183/09031936.03.00089403 22. Sly PD, Hayden MJ, Peták F, Hantos Z, Sly PD Petak F, Hantos Z HMJ. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 23. Sly PD, Hayden MJ, Peták F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 24. Lambrecht, B. N., & Hammad, H. (2015). The immunology of asthma. Nature immunology, 16(1), 45.25. Fórum Internacional de Sociedades Respiratórias. O Impacto Global da Doença Respiratória. European Respiratory Society. 2017. 26. Vasconcelos MM, Accioly LS, Leão MJCC, Lima DST, Aguiar Filho AS, Lopes Neto EPA, et al. Conceitos de asma e instrumentos de levantamentos epidemiológicos de prevalência. Rev Port Pneumol. 2015; 27. Wallace J, Denk C, Kruse L. PEER REVIEWED: Pediatric Hospitalizations for Asthma: Use of a Linked File to Separate Person-level Risk and Readmission. Prev Chronic Dis. 2004; 28. Cookson W. The alliance of genes and environment in asthma and allergy. Nature. 2002; 29. Busse WW, Lemanske Jr. RF. Asthma. N Engl J Med. 2001; 30. Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, et al. The burden of severe asthma in childhood and adolescence: Results from the paediatric U-BIOPRED cohorts. In: European Respiratory Journal. 2015. 31. Gray D, Willemse L, Visagie A, Czövek D, Nduru P, Vanker A, et al. Determinants of early-life lung function in African infants. Thorax. 2016; 32. Malmberg LP, Pelkonen a, Poussa T, Pohianpalo a, Haahtela T, Turpeinen M. Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging [Internet]. 2002 Jan [cited 2016 Jan 6];22(1):64–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12003103 33. Hall GL, Hantos Z, Petak F, Wildhaber JH, Tiller K, Burton PR, et al. Airway and respiratory tissue mechanics in normal infants. Am J Respir Crit Care Med [Internet]. 2000;162(4 I):1397–402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11029351 34. Sole D, Aranda CS, Wandalsen GF. Asthma: epidemiology of disease control in Latin America - short review. Asthma Res Pr [Internet]. 2017/05/17. 2017;3:4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28507765 35. Solé D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK, Group I-B. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3. J Pediatr (Rio J). 2006; 36. Sole D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC. Asthma in children and adolescents in Brazil: contribution of the International Study of Asthma and Allergies in Childhood (ISAAC). Rev Paul Pediatr. 2014; 37. Roncada C, de Oliveira SG, Cidade SF. et al. Burden of asthma among inner-city children from Southern Brazil. J Asthma. 2016; 38. Campos HS. Asma: suas origens, seus mecanismos inflamatórios e o papel do corticosteróide. Rev Bras Pneumol Sanitária. 2007; 39. Holgate ST. Pathogenesis of Asthma. In: Allergy and Allergic Diseases, Second Edition. 2009. 40. V Kumar, Jon C. Aster AA. Robbins & Cotran Patologia - Bases Patológicas das Doenças. Elsevier Brasil. 2015. 41. Martínez Aguilar NE. [Pathogenesis, trigger and risk factors in asthma]. Rev Alerg Mex. 2009; 42. Cockcroft DW. Direct challenge tests: Airway hyperresponsiveness in asthma: Its measurement and clinical significance. Chest. 2010. 43. Diagnóstico clínico e funcional da asma brônquica. Rev Assoc Med Bras. 2004; 44. Souza-Machado C, Souza-Machado A, Franco R, Ponte E V., Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J. 2010; 45. Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 46. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004; 47. LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: Validation of the Asthma Control Scoring System. Allergy Eur J Allergy Clin Immunol. 2007; 48. Using beta 2-stimulants in asthma. Drug Ther Bull [Internet]. 1997 Jan [cited 2019 Aug 9];35(1):1–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9282409 49. Adams, N, Bestall, J, Malouf R, et al. Beclomethasone versus placebo for chronic asthma ( Review ). Cochrane. 2008; 50. O’Byrne PM, Reddel HK, Eriksson G, Östlund O, Peterson S, Sears MR, et al. Measuring asthma control: A comparison of three classification systems. Eur Respir J. 2010; 51. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: An integrated analysis of zafirlukast trials. Thorax. 2000; 52. Drazen JM, Israel E, OʼByrne PM. Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. Surv Anesthesiol. 1999; 53. Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, et al. Low-dose inhaled fluticasone propionate versus oral zaf irlukast in the treatment of persistent asthma. J Allergy Clin Immunol. 2000; 54. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: An evidence-based approach. Med J Aust. 2003; 55. Diamant Z, Vijverberg S, Alving K, Bakirtas A, Bjermer L, Custovic A, et al. Towards clinically applicable biomarkers for asthma – An EAACI position paper . Allergy. 2019; 56. Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy: European Journal of Allergy and Clinical Immunology. 2015. 57. Hekking PP, Loza MJ, Pavlidis S, de Meulder B, Lefaudeux D, Baribaud F, et al. Pathway discovery using transcriptomic profiles in adult-onset severe asthma. J Allergy Clin Immunol. 2018; 58. Hekking PP, Loza MJ, Pavlidis S, De Meulder B, Lefaudeux D, Baribaud F, et al. Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J. 2017; 59. Zissler UM, Esser-Von Bieren J, Jakwerth CA, Chaker AM, Schmidt-Weber CB. Current and future biomarkers in allergic asthma. Allergy: European Journal of Allergy and Clinical Immunology. 2016. 60. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med [Internet]. 2009/06/02. 2009;180(5):388–95. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19483109 61. Reis AP dos, Machado JAN. Biomarcadores e imunobiológicos na asma. Brazilian J Allergy Immunol. 2019; 62. Almstrand AC, Ljungstrom E, Lausmaa, J. et al. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Analytical Chemistry. 2009. 63. Trivedi A, Hall C, Hoffman EA, Woods JC, Gierada DS. Clinical reviews in allergy and immunology Using imaging as a biomarker for asthma. J Allergy Clin Immunol. 2017; 64. Normansell R, Walker S, Milan SJ, Walters EH, P. N. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;13(1):1–109. 65. Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, et al. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma. N Engl J Med. 2014; 66. Nair P, Pizzichini MMM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia. N Engl J Med. 2009; 67. Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, et al. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma. N Engl J Med. 2014; 68. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial. Lancet. 2012; 69. Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015; 70. Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. In: Chest. 2016. 71. Castro M, Wenzel, SE. Bleecker ER. et al. Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: A phase 2b randomised dose-ranging study. The Lancet Respiratory Medicine. 2014. 72. Pereira CAC. Espirometria. J Pneumol . 2002;28. 73. Cruz AA, Fernandes AL, Pizzichini E, Fiterman J, Pereira LF, Pizzichini M, et al. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma - 2012. J Bras Pneumol 2012. 38:S1-46. 74. Pereira CADC. CONSENSO DE Espirometria. J Bras Pneumol. 2002; 75. Burity EF, Pereira CA de C, Rizzo JÂ, Sarinho ESC, Jones MH. Efeito da terminação precoce da expiração nos parâmetros espirométricos em crianças pré-escolares saudáveis. J Bras Pneumol. 2011; 76. França DC, Camargos PAM, Jones MH, Martins JA, Vieira B da SPP, Colosimo EA, et al. Prediction equations for spirometry in four‐ to six‐year‐old children. J Pediatr (Versão em Port. 2016; 77. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85–99. Available from: http://rc.rcjournal.com/cgi/doi/10.4187/respcare.01411 78. MacLeod D, Birch M. Respiratory input impedance measurement: Forced oscillation methods. Medical and Biological Engineering and Computing. 2001. 79. Sly PD, Hayden MJ, Peták F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med. 1996; 80. Bates JHT. Systems physiology of the airways in health and obstructive pulmonary disease. Wiley Interdiscip Rev Syst Biol Med. 2016; 81. Melo PL. Forced oscillation technique in pulmonology practice: principles and examples of potential applications. Pulmão RJ. 2015;24(1):42-48. 82. Shirai T, Kurosawa H. Clinical Application of the Forced Oscillation Technique. Intern Med [Internet]. 2016;55(6):559–66. Available from: https://www.jstage.jst.go.jp/article/internalmedicine/55/6/55_55.5876/_article 83. Johnson MK, Birch M, Carter R, et al. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax 2007; 62: 299–306. 84. Lorx A, Czovek D, Gingl Z, Makan G, Radics B, Bartusek D, et al. Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure. Eur Respir J [Internet]. 2017/02/17. 2017;49(2). Available from: https://www.ncbi.nlm.nih.gov/pubmed/28202552 85. Silva KKD da, Faria ACD, Lopes AJ, Melo PL de. Within-breath respiratory impedance and airway obstruction in patients with chronic obstructive pulmonary disease. Clin (São Paulo, Brazil) [Internet]. 2015 Jul [cited 2016 Jan 28];70(7):461–9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4496751&tool=pmcentrez&rendertype=abstract 86. Davidson RN Hussain A, Saunders KB GCA. Within-breath changes of airway calibre in patients with airflow obstruction by continuous measurement of respiratory impedance. Br J Dis Chest. 1986;80(4):335–52. 87. Veras TN, Pinto LA. Viabilidade da realização de espirometria em pré-escolares. J Bras Pneumol. 2011; 88. World Health Organization. Growth reference data for 5-19 years. Who Child Growth Stand. 2013; 89. de Onis M, Garza C, Onyango AW, Borghi E. Comparison of the WHO Child Growth Standards and the CDC 2000 Growth Charts. J Nutr. 2007; 90. Brasil. Resolução No 466, de 12 de dezembro de 2012. Diário of da União. 2012;
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Pontifícia Universidade Católica do Rio Grande do Sul
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Medicina/Pediatria e Saúde da Criança
dc.publisher.initials.fl_str_mv PUCRS
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Escola de Medicina
publisher.none.fl_str_mv Pontifícia Universidade Católica do Rio Grande do Sul
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da PUC_RS
instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron:PUC_RS
instname_str Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron_str PUC_RS
institution PUC_RS
reponame_str Biblioteca Digital de Teses e Dissertações da PUC_RS
collection Biblioteca Digital de Teses e Dissertações da PUC_RS
bitstream.url.fl_str_mv http://tede2.pucrs.br/tede2/bitstream/tede/9081/4/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpg
http://tede2.pucrs.br/tede2/bitstream/tede/9081/3/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txt
http://tede2.pucrs.br/tede2/bitstream/tede/9081/2/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf
http://tede2.pucrs.br/tede2/bitstream/tede/9081/1/license.txt
bitstream.checksum.fl_str_mv 986ee145064af681f7777c316248e20c
d16dc4aa8644cd0d4df8d4e5068696e0
35ffca4b472da18ca6d4d8fd09c9906f
220e11f2d3ba5354f917c7035aadef24
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da PUC_RS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
repository.mail.fl_str_mv biblioteca.central@pucrs.br||
_version_ 1799765343717031936